Characterization of human and rodent native and recombinant adenosine A2B receptors by radioligand binding studies

被引:21
|
作者
Bertarelli D.C.G. [1 ]
Diekmann M. [1 ]
Hayallah A.M. [1 ]
Rüsing D. [2 ]
Iqbal J. [1 ]
Preiss B. [1 ]
Verspohl E.J. [2 ]
Müller C.E. [3 ]
机构
[1] Pharmaceutical Institute, Pharmaceutical Sciences Bonn (PSB), University of Bonn, Bonn
[2] Institute of Pharmaceutical and Medicinal Chemistry, Department of Pharmacology, University of Münster, Münster
[3] Pharmazeutisches Institut, Pharmazeutische Chemie Poppelsdorf, Bonn 53115
关键词
[!sup]3[!/sup]H]PSB-298; A[!sub]2B[!/sub] antagonist radioligand; Adenosine A[!sub]2B[!/sub] receptor; CHO cells; HEK-293; cells; INS-1; NG108-15; Sodium shift assays;
D O I
10.1007/s11302-006-9012-4
中图分类号
学科分类号
摘要
Adenosine A2B receptors of native human and rodent cell lines were investigated using [3H]PSB-298 [(8-{4-[2-(2-hydroxyethylamino)-2-oxoethoxy]phenyl}-1-propylxanthine] in radioligand binding studies. [3H]PSB-298 showed saturable and reversible binding. It exhibited a KD value of 60 ± 1 nM and limited capacity (Bmax = 3.511 fmol per milligram protein) at recombinant human adenosine A2B receptors expressed in human embryonic kidney cells (HEK-293). The addition of sodium chloride (100 mM) led to a threefold increase in the number of binding sites recognized by the radioligand. The curve of the agonist 5′-N-ethylcarboxamidoadenosine (NECA) was shifted to the right in the presence of NaCl, while the curve of the antagonist PSB-298 was shifted to the left, indicating that PSB-298 may be an inverse agonist at A2B receptors. Adenosine A2B receptors were shown to be the major adenosine A2 receptor subtype on the mouse neuroblastoma x rat glioma hybrid cell line NG108-15 cells. Binding studies at rat INS-1 cells (insulin secreting cell line) demonstrated that [3H]PSB-298 is a selective radioligand for adenosine A2B binding sites in this cell line. © Springer Science + Business Media B.V. 2006.
引用
收藏
页码:559 / 571
页数:12
相关论文
共 50 条
  • [41] Adenosine A2B receptors:: a novel therapeutic target in asthma?
    Feoktistov, I
    Polosa, R
    Holgate, ST
    Biaggioni, I
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (04) : 148 - 153
  • [42] A2B adenosine receptors and growth inhibition in cancer cells
    Lorenz, Kristina
    Vidal, Marie
    Yadav, Rahul
    Bieber, Daniela
    Ruebeling, Karsten
    Sumski, Lena
    Heinlein, U-Ju
    Kachler, Sonja
    Klotz, Karl-Norbert
    PURINERGIC SIGNALLING, 2010, 6 : 89 - 89
  • [43] A2B adenosine receptors in tumor-host interaction
    Feoktistov, Igor
    Dikov, Mikhail
    Ryzhov, Sergey
    Biaggioni, Italo
    PURINERGIC SIGNALLING, 2010, 6 : 32 - 33
  • [44] Modulation of adenosine A2A rceptor function by A2B receptors
    Feoktistov, I
    Ryzhov, S
    Goldstein, A
    Matafonov, A
    Maa, T
    Zeng, DW
    Belardinelli, L
    Biaggioni, I
    HYPERTENSION, 2003, 42 (03) : 391 - 391
  • [45] Heteromeric association of A2A and A2B adenosine receptors.
    Ryzhov, S
    Goldstein, AE
    Feoktistov, I
    Biaggioni, I
    FASEB JOURNAL, 2002, 16 (04): : A196 - A196
  • [46] Characterization of potent ligands at human recombinant adenosine receptors
    Cristalli, G
    Camaioni, E
    Costanzi, S
    Vittori, S
    Volpini, R
    Klotz, KN
    DRUG DEVELOPMENT RESEARCH, 1998, 45 (3-4) : 176 - 181
  • [47] [3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors
    Stewart, M
    Steinig, AG
    Ma, CL
    Song, JP
    McKibben, B
    Castelhano, AL
    MacLennan, SJ
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (02) : 305 - 312
  • [48] Why are A2B receptors low-affinity adenosine receptors?: Mutation of Asn273 to Tyr increases affinity of human A2B receptor for 2-(1-hexynyl) adenosine
    Beukers, MW
    Den Dulk, H
    Van Tilburg, EW
    Brouwer, J
    Ijzerman, AP
    MOLECULAR PHARMACOLOGY, 2000, 58 (06) : 1349 - 1356
  • [49] Differential expression of adenosine receptors in human endothelial cells -: Role of A2B receptors in angiogenic factor regulation
    Feoktistov, I
    Goldstein, AE
    Ryzhov, S
    Zeng, DW
    Belardinelli, L
    Voyno-Yasenetskaya, T
    Biaggioni, I
    CIRCULATION RESEARCH, 2002, 90 (05) : 531 - 538
  • [50] Differential expression of adenosine receptors in human endothelial cells:: Role of A2B receptors in angiogenic factor regulation
    Feoktistov, I
    Goldstein, AE
    Ryzhov, S
    Zang, DW
    Belardinelli, L
    Voyno-Yasenetskaya, T
    Biaggioni, I
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A70 - A70